Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 7,410 shares at $43.85 ($325K) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Scheduled sale ($325k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.85 | 3,705 | $162K | 50.0% |
| 2 | $43.85 | 3,705 | $162K | 50.0% |
| Total | $43.85 avg | 7,410 | $325K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |